New orally bioavailable 2-aminobenzamide-type histone deacetylase inhibitor possessing a (2-hydroxyethyl)(4-(thiophen-2-yl)benzyl)amino group - Kiyokawa, S; Hirata, Y; Nagaoka, Y; Shibano, M; Taniguchi, M; Yasuda, M; Baba, K; Uesato, S (Bioorg Med Chem, 2000)